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INTRODUCTION
Interferons (IFNs) are well known for both their in vitro and in vivo antiproliferative effect and immunomodulatory activity, 1,2 and they were the first cytokines to be applied clinically in human cancer. 3, 4 Despite the demonstrated clinical effectiveness, the treatment with IFNa/b is associated with substantial systemic toxicity that worsens the patient's quality of life and often prejudices the therapy completion (B25% of the treated patients). 5 The antiproliferative effect, however, relies on IFNb concentrations that cannot be achieved by systemic protein administration because of toxicity, an extremely short half-life in the blood stream and rapid protein clearance. Pharmacokinetic studies indicate that the limited performance of IFNb in cancer trials may have been caused by insufficient or lack of sustained delivery of the protein to the tumor site. 6 A continuous, low-level delivery of IFN might avoid its toxicity while maintaining, and probably improving, its antitumor efficacy. This type of pharmacokinetics could be achieved by a gene therapy-mediated approach. Thus, gene transfer would allow taking advantage of IFNa/b effectiveness without undesirable side effects.
Even though murine IFNb adenoviral gene transfer was successfully applied for murine colorectal cancer liver metastases in immune-competent BALB/c mice, 7 the use of viral vectors carrying IFNa/b, cytokines that trigger antiviral responses, does not seem to be the best choice a priori. Both innate and acquired immunity toward adenovirus were described, a situation even more sensitive when the treatment should be repeated to reach a significant clinical outcome. In the case of a clinical trial for mesothelioma, 8 neutralizing antibodies against recombinant adenoviral particles carrying human hIFNb (hIFNb) gene prevented further rounds of transduction. Whereas safety and feasibility of the treatment were assessed, the clinical benefits resulted still poor. In this scenario, nonviral vectors carrying IFNa/b would not be limited by such constraints, as it was already proposed. 3 Cationic liposomes allowed multiple in vivo administrations of plasmids carrying therapeutic genes, 9 sometimes achieving long-term survival rate. 10, 11 In the case of human glioma, the preliminary clinical effects obtained with adenoviral vectors 12 do not seem more encouraging than those obtained with liposomal vectors. 13 Because local nonviral gene therapy has the potential to overcome the above-mentioned limitations, one of the aims of this study was to evaluate the in vitro antitumor activity of hIFNb gene therapy compared with rhIFNb protein in Ewing's sarcoma (ES) and other human tumor models. This proposal was based on: (1) our previous encouraging clinical data from veterinary soft tissue sarcoma patients 11 and (2) the demonstration that recombinant human IFNa and IFNb inhibited the in vivo growth of established ES xenografts generated by the same cell lines used by us (EW7, COH). 14 The study of the mechanisms achieving to cell death and bystander effect induced by hIFNb gene lipofection, probably involving reactive oxygen species, may provide a deeper insight on the action of this approach for gene therapy.
MATERIALS AND METHODS

Cell cultures
Human ES (EW7 and COH), 14 melanoma (M8), 15 mammary carcinoma (MCF7, ATCC, Manassas, VA, no. HTB-22) and colorectal adenocarcinoma (HT-29, ATCC no. HTB-38) cells were cultured at 37 1C in a humidified atmosphere of 95% air and 5% CO 2 with Dulbecco's modified Eagle's medium (DMEM)/F12 medium (Invitrogen, Carlsbad, CA) containing 10% fetal bovine serum (Invitrogen), 10 mM HEPES (pH 7.4) and antibiotics. Serial passages were done by trypsinization (0.25% trypsin and 0.02% EDTA in phosphate-buffered saline (PBS)) of subconfluent monolayers.
Plasmids
Plasmids psCMVb and psCMV-hIFNb were built replacing the HSV thymidine kinase gene of psCMVtk 10 by Escherichia coli b-galactosidase (bgal) 16 and hIFNb genes, respectively. Plasmids were amplified in E. coli DH5a (Invitrogen), grown in LB medium containing 100 mg ml À1 neomycin and purified by ion-exchange chromatography (Qiagen, Valencia, CA).
Liposome preparation and in vitro lipofection ,N 0 -dimethylaminoethane)-carbamoyl cholesterol) and DMRIE (1,2-dimyristyloxypropyl-3-dimethyl-hydroxyethilammonium bromide) were synthesized and kindly provided by BioSidus (Buenos Aires, Argentina). DOPE (1,2-dioleoyl-sn-glycero-3-phosphatidyl ethanolamine) was purchased from Sigma (St Louis, MO). Liposomes were prepared at lipid/co-lipid molar ratios of 3:2 (DC-Chol:DOPE) or 1:1 (DMRIE:DOPE) by sonication as described. 16 Optimal lipid mixtures were determined for every cell line. Cultured cells at a density of 5 Â 10 4 cells per cm 2 (B40% confluence) were exposed to lipoplexes (1 ml liposomes per cm 2 and 0.5 mg DNA per cm 2 ) during 4--6 h.
bgal staining
To measure gene transfer efficiency, psCMVb-lipofected cells were trypsinized, fixed in suspension, stained with 5-bromo-4-chloro-3-indolyl b-D-galactopyranoside (X-GAL, Sigma) and counted using an inverted phase contrast microscope. 16 Sensitivity to hIFNb assay At 24 h after lipofection, transiently hIFNb-or bgal-expressing cells, were seeded on regular plates (5 Â 10 4 cells per ml). Alternatively, nonlipofected cultured cells were treated with recombinant human IFN-a2b (Bioferon) or IFN-b2a (Blastoferon) kindly provided by BioSidus at the indicated concentrations. After 5 days of incubation, cell viability was quantified using a colorimetric CellTiter 96 Aqueous Non radioactive MTS Cell Proliferation Assay according to the manufacturer's instructions (Promega, Madison, WI). The percentage of cell survival was calculated from the ratio of the absorbances between lipofected and untreated control cells.
Flow cytometry cell cycle analysis
Untreated cells or both hIFNb-or bgal-expressing cells were trypsinized, fixed in 70% (v/v) ethanol at À20 1C for 1 h, treated with RNase, stained with 10 mg ml À1 propidium iodide for 30 min, and subjected to single- 
DNA ladder assay
Total genomic DNA was isolated from untreated or both hIFNb-or bgalexpressing EW7 cells by SDS/Proteinase K lysis followed by phenol/ chloroform extraction and ethanol precipitation, and then incubated with RNase A and electrophoretically separated on 1.2. % agarose gels stained with ethidium bromide.
Senescence
Senescence-associated expression of bgal activity was determined as described. 17 In brief, untreated, treated with 3 consecutive daily pulses of 1000 or 10 000 IU ml À1 rhIFNb or both hIFNb-or bgal-expressing EW7 cells were trypsinized, fixed in suspension and incubated in acidic condition with X-GAL (Sigma), 0.12 mM K 3 Fe(CN) 6 , 0.12 mM K 4 Fe(CN) 6 , 1 mM MgCl 2 in PBS, pH 6.5, at 37 1C overnight. Then, blue cells were counted using an inverted phase contrast microscope.
Mitochondrial potential evaluation
Mitochondrial membrane potential was evaluated by simultaneous staining with MitoTracker Red CMXRos (Invitrogen) 18 and calcein-AM (Invitrogen). 19 Briefly, control (untreated), bgal and hIFNb-lipofected cells were incubated with 0.1 mM final concentration of both probes (pH 7.4, PBS) for 20 min, washed with PBS and then incubated in fresh DMEM/F12 medium for 30 min. Whereas accumulation of MitoTracker Red CMXRos (red staining) demonstrates a conserved mitochondrial potential, calcein-AM (green staining) marks all viable cells. Fluorescent images were captured with the above-mentioned microscope.
Intracellular reactive oxygen species detection
Intracellular oxidants levels were detected by DHDCFDA (Invitrogen). 20 Control (untreated), bgal and hIFNb-lipofected cells were incubated with 0.1 mM final concentration of DHDCFDA (DMEM/F12 without fetal bovine serum) for 20 min, washed with PBS and then incubated in normal culture conditions. Fluorescent images were captured with the above-mentioned microscope. The total number of cells was evaluated using an inverted phase contrast microscope.
Chromogenic detection of superoxides As described, 21 250 mM nitro blue tetrazolium salt (NBT) dissolved in 70% dimethyl formamide in the culture medium was added to untreated EW7 cells, treated with consecutive daily pulses of 3000 IU ml À1 rhIFNb or lipofected with hIFNb or bgal genes cells for 6 h. When reacting with superoxide, NBT forms a water-insoluble blue formazan. Cells were then incubated for 20 min in a solution of 20% SDS and 50% dimethylformamide and detached from 24-well plates with a rubber policeman. The cell solution was boiled for 1 min to dissolve formazan crystals. After cell debris removal by brief spin down, absorbance was read at 570 nm.
Measurement of hydroperoxide (ROOH) concentrations in culture media
The concentration of H 2 O 2 in the culture medium was measured by the Fe 2 þ oxidation-xylenol orange method 22 as follows: 100 ml medium of untreated or both hIFNb-or bgal-expressing EW7 cells was mixed with 
Cellular antioxidant capacity assay
The determination of the antioxidant capacity of cells was adapted from the previously described luminol test. 23 Briefly, a PBS solution of 1 Â 10 6 ml cells of control (untreated), bgal-and hIFNb-lipofected cells was incubated with 0.1 mM luminol final concentration and 1 mM H 2 O 2 . The chemoluminescence of oxidized luminol was evaluated immediately, every 20 s, 25 times. Results were expressed as percentages of the values obtained for untreated cells (100%; n ¼ 4).
Addition of exogenous antioxidant enzymes
After bgal or hIFNb gene lipofection or the addition of 1000 or 3000 IU ml À1 of rhIFNb, cell culture medium was supplemented with 100 IU ml À1 superoxide dismutase (SOD) or 1000 IU ml À1 catalase (CAT) or a combination of both antioxidant enzymes.
Supernatant cytotoxicity
The supernatants of control (untreated), bgal-and hIFNb-lipofected cells were collected (48 h after lipofection), filtered (0.22 mm) and incubated at 37 or 92 1C for 3 min. EW7 untreated cells were cultured as monolayer for 24 h and then media were removed and replaced by control (untreated), bgal-and hIFNb-lipofected supernatants. Cell viability was evaluated with MTS as described above.
hIFNb antiviral biological activity
The supernatants of control (untreated), bgal-and hIFNb-lipofected cells were collected (24 h after lipofection) and assayed by a biological method. 24 Wish cells were used as biological substrate and vesicular stomatitis virus was employed as challenge. IFN produced was always b type, as it was completely neutralized by a monoclonal anti-hIFNbneutralizing antibody kindly provided by BioSidus.
Statistics
Results were expressed as mean±s.e.m. (n: number of experiments corresponding to independent assays). Differences between groups were determined by analysis of variance.
RESULTS AND DISCUSSION rhIFNb displayed a stronger cytotoxic effect than rhIFNa Human cell lines derived from different kinds of tumors (EW7, COH: ES; M8: melanoma; MCF7: mammary adenocarcinoma; HT-29: colon adenocarcinoma) were in vitro incubated with 3 consecutive daily pulses of fixed concentrations (1--10 000 IU ml produced a concentration-dependent inhibition of proliferation, with the exception of HT-29 that resulted refractory to rhIFNa. It is noteworthy that the cytotoxic effect caused by rhIFNb was always higher than that caused by the equivalent amount of rhIFNa. The maximal rhIFNa inhibition (between 30 and 20%) of EW7, COH, M8 and MCF7 was significant (Po0.01) only at the maximal tested concentration (10 000 IU ml À1 ). At the tested range, rhIFNa did not reach the half-maximal inhibitory concentration (IC 50 ) in any tumor cell line, and hence the IC 50 s for this protein could not be established. On the other hand, COH cells started to be significantly sensitive to rhIFNb from 10 IU ml À1 (Po0.01), and EW7 and MCF7 did so from 100 IU ml À1 (Po0.01), whereas M8 was sensitive only at 10 000 IU ml À1 (Po0.05). As defined by the rhIFNb IC 50 s, COH, EW7 and MCF7 cells resulted, respectively, at least 70-, 12-and 6-fold more sensitive to rhIFNb than to rhIFNa. M8 and HT-29 cell survival curves always appeared rightward from the other ones, indicating a significant resistance to hIFNb and precluding the calculation of the IC 50 s (Figure 1c ).
Lipofection with hIFNb gene showed a significant cytotoxic effect To establish the feasibility of a nonviral gene therapy achieved by lipoplexes carrying the hIFNb gene, we lipofected the abovementioned cell lines. As shown in Figure 1d , viability of bgalexpressing EW7, COH, M8 and HT-29 ranged 75--95%, whereas in the case of MCF-7 it was only 45%, possibly because lipoplex treatment stimulated the expression and release of hIFNb. 25 The transfer of hIFNb gene produced an additional strong cell viability inhibition (50%) in EW7, COH, MCF7 and M8. HT-29 resulted only moderately sensitive to hIFNb gene (30%). Taking into account the low lipofection efficiencies of ES, melanoma and colon adenocarcinoma cells (Figure 1c ), this outcome result was very encouraging.
As displayed in Figure 1c , the levels of biologically active hIFNb protein secreted by lipofected cells 24 h after gene transfer varied from B1000 to 3000 UI ml À1 per day, reflecting the balance between protein synthesis/secretion and degradation in the culture medium. It is worth noting that these levels did not correlate with cytotoxic effects, probably because of: (1) the different susceptibility of each tumor cell line, or (2) the effect of extracellular rhIFNb could be spare or redundant with respect to the endogenously synthesized cytokine.
Highly sensitive COH and EW7 cells and poorly sensitive HT-29 cells displayed no significant differences between hIFNb-lipofected gene and the exogenously added recombinant protein (10 000 IU ml À1 ). Conversely, the cytotoxic effects of the lipofected hIFNb gene resulted significantly higher in M8 and MCF7 than those of 3 daily additions of exogenously added rhIFNb at the concentration produced by the lipofected cells (Figures 1b--d) . This indicates that hIFNb gene lipofection might have a broader spectrum of cytotoxic effects than those triggered by exogenous recombinant hIFNb protein.
Lipofected hIFNb gene enhanced the fraction of hypodiploid sub G 1 apoptotic cells To get a deeper insight on the mechanisms involved in the effects of hIFNb lipofection, we analyzed hIFNb-lipofected EW7 cells by flow cytometry (Figures 2a--e) . EW7 cells were not sensitive to bgal lipofection, displaying the typical cell cycle peaks G 0 /G 1 , S and G 2 /M (like nonlipofected control cells: Figure 2e ) and a slight increase in the sub-G 1 apoptotic region (from 3 to 9% at day 5). Conversely, from day 1 after lipofection, hIFNb gene increased the fraction of G 0 /G 1 , S, G 2 /M and hyperdiploid cell populations. After 5 days, 87% of the total hIFNb-lipofected cells accumulated in the hypodiploid sub-G 1 apoptotic region, whereas the fraction of cycling and hyperdiploid cell populations reduced drastically.
On the other hand, hIFNb-induced DNA damage was confirmed by agarose gel electrophoresis of extracted genomic DNA (Figure 2f) . A smear of degraded DNA clearly appeared from 96 to 120 h after initiation of treatment, with no evidence of a nucleosomal ladder, probably because of the increase of oxidant species. 26 Lipofected hIFNb gene induced distorted cell phenotypes By means of hematoxylin and eosin staining (Figure 3 ), all hIFNblipofected cell lines displayed significant morphological changes like cell volume increase (EW7), nuclear fragmentation (EW7), cytoplasmic vacuolization (M8) and condensed and pycnotic nuclei (all). MCF7 resulted particularly sensitive, showing substantial swelling after unspecific lipofection with bgal gene. Conversely, HT-29 displayed some degree of swelling after lipofection with bgal gene, without the concomitant cytoxicity.
In the cases of hIFNb-lipofected EW7 and MCF7 cells, the presence of multinucleated giant cells was congruent with hyperdiploid apoptotic cells from the flow cytometry patterns (Figures 2 and 3) .
Lipofected hIFNb gene efficiently drove cells to death through necrosis or apoptosis Double staining with acridine orange/ethidium bromide 27 allowed the observation of apoptotic/necrotic events following lipofection with bgal and hIFNb genes. Cell membrane is permeable to acridine orange, leading to a homogeneous green cell staining. Ethidium bromide enters only in dying or dead cells because of the disruption in the plasmatic membrane integrity and, consequently, the compact chromatin becomes red-stained. As shown in Figure 4a , control and bgal-lipofected EW7, M8 and MCF7 mostly appeared as green-stained healthy cells. Lipofection with hIFNb increased the number of apoptotic/necrotic events as evidenced by the increase of red-stained nuclei. In EW7, this effect, which was not detectable at 24 h, became significant between 72 and 120 h after lipofection. During this process, condensed chromatin appeared in EW7 apoptotic cells as well as red swollen necrotic cells (data not shown). At 120 h after lipofection, M8 displayed clear images of apoptotic events with a significant reduction of total cell number. MCF7 significantly increased the fraction of damaged cells distributed between apoptotic and necrotic events.
As derived from counting of ethidium bromide-stained cells 5 days after gene transfer, 87% of hIFNb-lipofected EW7 cells appeared involved in apoptosis/necrosis as compared with only 9% of bgal-lipofected cells. In the lipofection-sensitive MCF7 cells, B20% of bgal-and 50% of hIFNb-lipofected cells were involved in apoptosis/necrosis pathways. Nearly 30% of M8 cells (quite resistant to rhIFNb protein) were involved in apoptosis/necrosis as compared with only 8% of bgal-lipofected cells. Control unlipofected cells displayed a basal rate of apoptosis/necrosis ranging 1--3% under our culture conditions. Lipofected hIFNb gene engaged the p53 tumor-suppressor pathway Interestingly, IFNb expression has also been associated with upregulation of tumor-suppressor gene p53, a central regulator of the senescence response. 28 This factor plays a pivotal role in growth regulation and cell death under stress conditions. The p53 tumor-suppressor pathway is activated when the redox balance is modified, and its specific binding to DNA activates target genes. 29 As mentioned above, hIFNb gene transfer blocked the cell cycle progression and triggered apoptosis (Figures 2 and 4a) . In EW7 at 48 h after lipofection (Figure 4b) , specific immunofluorescence evidenced a significant increase of nuclear and total p53 as confirmed by western blot (Figure 4b, central inset) . Western bands displayed 85% stronger expression of p53 triggered by hIFNb with respect to bgal-lipofection (quantified with ImageJ 1.45s; NIH, software). The basal p53 levels of untreated controls were barely detected (B5% of those produced bgal lipofection). The appearance of cytoplasmic discrete dots (Figure 4b , right inset), possibly because of a mitochondrial translocation of p53, is noteworthy. Both phenomena were reported as related to oxidative stress. 30 Lipofected hIFNb gene depolarized the mitochondrial membrane In general, cancer cells display a basal hyperpolarization of the mitochondrial membrane that confers them a certain degree of resistance. 31 As it has been described in Figure 1c , M8 resulted resistant to rhIFNb protein compared with EW7 (IC 50 410 000 vs IC 50 : 800 IU ml À1 , respectively), whereas both cell lines resulted sensitive to hIFNb gene. One of the reasons of this difference may be because of the fact that only hIFNb gene depolarized mitochondrial membrane in M8 (Figure 4c) , thus reverting the basal hyperpolarization displayed by this resistant cell line. On the other hand, both rhIFNb protein and hIFNb gene decreased the mitochondrial potential in EW7, justifying the high sensitivity of this ES cell line.
Early senescence induced by hIFNb contributed to cell death To determine the status of the cells that apparently survived the treatment with hIFNb gene, we assayed the cellular acidic senescence-associated bgal activity (SA-bgal). 32 As shown in Figure 5b , at day 7 after lipofection with hIFNb, 50% of EW7 cells stained for SA-bgal. But these cells comprised those that survived the treatment, B40% of the initial cells. This means that 20% of the initial cells finally entered early senescence and only 20% remained viable. Furthermore, the addition of exogenous rhIFNb (3 consecutive days, Figure 5a ) displayed an increase of SA-bgal-positive cells proportional to the concentration, reaching at 10 000 IU ml À1 , values similar to those obtained by lipofection with hIFNb.
These results indicate that early senescence would be associated specifically to hIFNb rather than to lipofection procedure effects.
hIFNb transgene expression displayed a remarkable bystander effect Because IFNb is secreted out of cells, we would expect both autocrine and paracrine effects, resulting in a very significant bystander effect. The extent of cytotoxicity due to hIFNb gene transfer and expression (Figure 1d ) widely exceeded the lipofection efficiencies (Figure 1c ). In the case of EW7, only 1% of lipofected cells produced 460% of cell death, suggesting the occurrence of a strong bystander effect. This was confirmed by the fact that the dilution of hIFNb-lipofected EW7 cells with control bgal-lipofected EW7 cells up to 50% (that actually means 0.50% of positive bgal-expressing cells) did not significantly modify the cytotoxic effect (Figure 6a) . Only when the decreasing proportion of hIFNb-lipofected cells reached 0.25%, the cytotoxicity significantly diminished (Po0.05). In addition, we found that hIFNb-lipofected (but not bgallipofected) EW7 cell supernatant displayed cytotoxic effect when added to nontreated EW7 cells (Figure 6b ). The incubation of this supernatant at 92 1C during 3 min for hIFNb denaturation partially decreased its cytotoxicity, indicating the possible involvement of additional thermostable bystander factors (data not shown).
Even though with much higher gene transfer efficiencies, a bystander effect for adenoviral-mediated IFN-a (Ad-IFNa) was previously reported. Ad-IFNa was cytotoxic both to cancer cells that are sensitive and to those that are resistant to rhIFNa. Three different mechanisms were proposed: (1) the direct effect of hIFNa production in rhIFNa-sensitive cells; (2) the direct effect of Ad-IFNa infection and high levels of hIFNa expression in rhIFNa-resistant cancer cells; and (3) the indirect effect of the Ad-IFNa bystander factors produced. 33 Lipofected hIFNb gene increased the production of reactive oxygen species In accordance with the results on the decrease of mitochondrial potential (Figure 4c ), we also found that both hIFNb gene and rhIFNb protein increased intracellular oxidant species in EW7 (Figure 7a ), whereas only hIFNb gene did so in M8 (data not shown). These results suggest that both mitochondrial membrane depolarization and oxidative stress may be required for the antitumor IFN actions.
In addition, starting at 48 h after lipofection, hIFNb significantly (Po0.02) increased the superoxide anion (O 2 À ) production by EW7 (Figure 7b À . In addition, we evaluated whether ROOHs, which are able to cross cell membrane, were present in the extracellular media. As shown in Figure 7c , lipofection with hIFNb gene also produced a significant increase (Po0.05) in ROOHs on or after 72 h of treatment. This increase in ROOH levels could be because of a higher production or lower activity of degrading enzymes (that is, CAT) or to a combination of both events. Preliminary results demonstrated that an unspecific inhibitor of peroxidases 34 was increased in the cytosolic compartment of hIFNb-expressing EW7 cells (data not shown). On the other hand, we found that hIFNb gene decreased the antioxidant capacity of EW7 cells (Figure 7d ). To ascertain the involvement of oxidant species present in the extracellular media as mediators of hIFNb-induced cell killing, we added 100 IU ml À1 SOD, 1000 IU ml À1 CAT or a combination of both enzymes to the culture media of untreated, rhIFNb-treated or both hIFNb-or bgal-expressing EW7 and M8 cells (Figure 8 ). Even though separately they showed no effects, the combination of CAT plus SOD was able to partially revert the strong cytotoxic effect of hIFNb gene lipofection (from 50 to 25%, Po0.05) and almost completely blocked the low cytotoxic effect of 3000 IU ml À1 rhIFNb (from 30 to 10%; Po0.01) in M8. In the case of ES cell line, we found that the strong cytotoxic effect of 3000 IU ml À1 rhIFNb was partially reverted (from 75 to 60%, Po0.05) by the combination of the antioxidant enzymes. No significant effects were observed on hIFNb-lipofected EW7 cells.
CONCLUSION
A better understanding of the antitumor mechanisms and the identification of the factors responsible for resistance to IFNb gene lipofection could lead to its improved use in malignant and other diseases.
As already reported, 2,14 here we confirmed that the cytotoxic response induced by rhIFNb was superior to that of rhIFNa on all tested cell lines. Most relevant to the present work was the demonstration of that hIFNb gene lipofection could constitute an approach that produces an equivalent or higher effect than elevated doses of the exogenously applied protein rhIFNb ( Figure 1) .
As intracellular hIFNb RNA concentration was suggested as positive regulator of endogenous hIFNb antitumor activity, 35 a more complex mechanism of action would be involved in cells expressing hIFNb and their neighbors than in cells receiving it exogenously.
Even though lipofected hIFNb gene drove 20% of tumor cells to early senescence, the dramatic reduction in the viability of EW7, COH, M8 and MCF7 cells appeared to be primarily the result of apoptotic and necrotic events (Figures 2 and 4) . After 5 days of hIFNb gene lipofection, 87% of the total EW7 cells accumulated in the hypodiploid sub-G 1 apoptotic/necrotic region (Figure 2d) .
One of the main reasons for the success of hIFNb gene treatment would be the strong bystander effect promoted by this cytokine. This effect eliminated up to 60% of the ES cells, even though only 1% of them expressed measurable amounts of transgene. The high effectiveness of transgenic hIFNb agrees with previous reports demonstrating that as few as 1% of implanted cells (ex vivo IFNb gene transduced by a replication-defective adenovirus) blocked in vivo tumor formation. 36 Taking into account the considerably low hIFNb gene transfer and expression, the successful killing of such high proportion of ES cells was an unexpectedly good outcome (Figure 1 ). On the other hand, the other treatment that relies on the bystander effect, the suicide system HSVtk/GCV, 16 did not work on these cells (data not shown). This difference suggests that HSVtk/GCV probably requires a higher basal percentage of lipofection efficiency to work, thus proposing hIFNb as a less limited approach in this kind of therapy. We also may argue that the main difference between both systems is the fact that hIFNb can be secreted by the lipofected cells and thereby reach their nonlipofected neighbors. Then, we could expect both autocrine and paracrine effects, perhaps resulting in a very significant bystander effect. Nevertheless, in the case of M8 and MCF7, the treatment with 3 daily additions of a high concentration of rhIFNb protein produced a lower response than hIFNb gene lipofection. Then, the powerful bystander effect of the lipofection with hIFNb gene supports the involvement of additional cell death mediators.
In agreement with this hypothesis, we found that only hIFNb gene significantly depolarized mitochondrial membrane in M8 cells (Figure 4c ), thus reverting their basal hyperpolarization that confers them a certain degree of resistance. 31 On the other hand, both rhIFNb protein and hIFNb gene decreased the mitochondrial membrane potential in EW7-sensitive cell line (Figure 7a ). In addition, this decrease in mitochondrial potential was simultaneous to an increase in oxidative stress caused by hIFNb gene in both cell lines (Figure 7a and data not shown). We found an increase in superoxide anion simultaneous to a decrease in the antioxidant capacity of EW7 cells. Furthermore, we also demonstrated that the ROOHs produced by hIFNb-lipofected EW7 cells were able to reach adjacent unmodified tumor cells, leading them to oxidative damage (Figure 7b ). This phenomenon would activate amplification mechanisms allowing that few hIFNb-lipofected cells trigger the destruction of a high proportion of bystander cells. These results agree with previous studies that reported an essential role of mitochondria in the rhIFNb-induced cancer cell death. 37 As displayed in Figure 1b , melanoma M8 and colon carcinoma HT-29 cell lines were highly resistant to rhIFNb protein whereas ES EW7 and mammary adenocarcinoma MCF7 were more sensitive. This pattern significantly changed when hIFNb gene lipofection was done (Figure 1d ), making M8 as sensitive to the cytokine treatment as EW7. Whereas the recombinant protein is reaching cells from outside, the hIFNb transgene is also being synthesized and acting from the inside. A previous report showed that a truncated hIFNb that cannot be secreted by transfected cells was able to display biological activities similar to those of extracellular hIFNb. 38 Thus, a different regulatory pathway could be responsible for the strong bystander effect in a context of low gene transfer efficiency and expression. Possibly, reactive oxygen species and other small pro-apoptotic molecules involved in such effects can pass or diffuse from lipofected cells to their neighbors via intercellular channels. The fact that EW7 cells appeared intimately associated with each other as cell aggregates in which single cells could not be clearly distinguished could support this hypothesis. In this context, hIFNb protein displayed its cytotoxicity when exogenously added or secreted by neighboring cells (as demonstrated with the conditioned media). But the effect of extracellular rhIFNb could be spare or redundant when the strong bystander effect is triggered by the endogenously synthesized cytokine. This assumption is also supported by these facts: (1) the levels of rhIFNb in the culture medium of hIFNb-lipofected cells (Figure 1c ) did not correlate with its cytotoxic effects, and (2) the combination of the antioxidant enzymes (SOD þ CAT) was able to partially revert the strong cytotoxic effect of 3000 IU ml À1 rhIFNb protein, but not the effect of hIFNb lipofection in EW7 cells.
These data, together with the (1) high number of cells with degraded DNA (Figures 2d and f) , and (2) the upregulation ( Figure 4b ) and possible mitochondrial translocation of the tumorsuppressor gene p53, strongly emphasize the role of reactive oxygen species as mediators of hIFNb lipofection bystander effects. This situation may drastically differ from the mechanism of exogenously added rhIFNb, which depended on tumor cell features. In this study, hIFNb gene resulted highly more effective than rhIFNb, in particular when cells displayed a resistance phenotype, as it was found for M8.
It is also worth pointing out that our in vitro system does not include any of the immune mechanisms that could provide À1 of rhIFNb (a, b) were supplemented with 1000 IU ml À1 catalase (CAT; C), 100 IU ml À1 superoxide dismutase (SOD; S) or a combination of both antioxidant enzymes (C þ S). Cell viability was quantified by MTS at day 5 as described in the Materials and methods. Results are expressed as means ± s.e.m of four independent experiments. **Po0.01, *Po0.05 with respect to no additions. additional antitumor activity. Then, our findings strongly support the hIFNb gene transfer as a very promising strategy for cancer treatment.
